1428238-30-5

Basic information

• Product Name: methyl (6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-α-L-idopyranosyluronate)-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside
• Synonyms: methyl (6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-α-L-idopyranosyluronate)-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside
• CAS NO: 1428238-30-5
• Molecular Weight: 1627.84
• Mol File: 1428238-30-5.mol

Chemical Properties

• CAS DataBase Reference: methyl (6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-α-L-idopyranosyluronate)-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-α-L-idopyranosyluronate)-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside(1428238-30-5)
• EPA Substance Registry System: methyl (6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-β-D-glucopyranosyluronate)-(1→4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-(methyl 2,3-di-O-methyl-α-L-idopyranosyluronate)-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside(1428238-30-5)

Safety Data

• Hazardous Substances Data: 1428238-30-5(Hazardous Substances Data)

Upstream product

• 1428238-29-2 methyl (6-O-benzyl-2,3,4-tri-O-methyl-α-D-glucopyranosyl)-(1→4)-(methyl 3-O-methyl-β-D-glucopyranosyluronate)-(1→/4)-(2,3,6-tri-O-benzyl-α-D-glucopyranosyl)-(1→4)-(methyl 3-O-methyl-α-L-idopyranosyluronate)-(1→/4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside 
• 74-88-4 methyl iodide 

Relevant articles and documents

Novel syntheses of Idraparinux, the anticoagulant pentasaccharide with indirect selective factor Xa inhibitory activity

Idraparinux, the fully O-sulfated, O-methylated, heparin-related pentasaccharide possessing selective factor Xa inhibitory activity, was prepared by two novel synthetic pathways. Each route was based on a 2+3 block synthesis utilizing the same l-iduronic acid-containing trisaccharide acceptor, which was glycosylated with either a glucuronide disaccharide donor or its non-oxidized precursor. The latter route, involving the oxidation of the glucose unit into d-glucuronic acid at a pentasaccharide level proved to be much more efficient, providing the target pentasaccharide in a reasonable overall yield.